Custom cancer treatment trial aims to match therapy to patient risk
Disease control
Not yet recruiting
This study is testing whether personalized treatment plans based on a patient's specific genetic risk factors can better control multiple myeloma, a blood cancer. Researchers will assign different treatment combinations to 200 newly diagnosed patients depending on whether they ha…
Sponsor: FengYan Jin • Aim: Disease control
Last updated Mar 23, 2026 15:19 UTC